Biden administration buys more monoclonal antibody treatments to ward off shortage
(HealthDay)—As severe cases of COVID-19 rise and demand surges for monoclonal antibody treatments, the U.S. government is ordering more from two key suppliers.
Sep 16, 2021
0
9